99mTc-radiolabeled HER2 targeted exosome for tumor imaging
- PMID: 32198014
- DOI: 10.1016/j.ejps.2020.105312
99mTc-radiolabeled HER2 targeted exosome for tumor imaging
Abstract
Exosomes represent unique features including nontoxicity, non-immunogenicity, biodegradability, and targeting ability that make them suitable candidates for clinical applications. Therefore, in this study, 99mTc-radiolabel HER2 targeted exosomes (99mTc-exosomes) were provided for tumor imaging. These exomes are obtained from genetically engineered cells and possessed DARPin G3 as a ligand for HER2 receptors. These exosomes were radiolabeled using fac-[99mTc(CO)3(H2O)3]+ synthon. The quality control showed high radiochemical purity (RCP) for 99mTc-exosomes (>96%). 99mTc-exosomes displayed a higher affinity toward SKOV-3 cells (higher HER2 expression) in comparison with MCF-7, HT29, U87-MG, A549 cell lines at different levels of HER2 expression. Trastuzumab (an antibody with a high affinity toward HER2) inhibited the binding of 99mTc-exosomes to SKOV-3 cells up to 40%. Biodistribution study in SKOV-3 tumor bearing nude mice confirmed the ability of 99mTc-exosomes for accumulation in the tumor. 99mTc-exosomes can visualize tumor in SKOV-3 tumor-bearing nude mouse. The blockage of HER2 receptors using trastuzumab (excessive amount) suggests the 99mTc-exosomes binding to the receptors and reduced the accumulation of 99mTc-exosomes in the tumor site. This suggest that 99mTc-exosomes interact with HER2 receptors and act through specific targeting.
Keywords: (99m)Tc; HER2; Radiolabeling; Tumor targeting; exosome.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Monitoring therapeutic response of human ovarian cancer to trastuzumab by SPECT imaging with (99m)Tc-peptide-Z(HER2:342).Nucl Med Biol. 2015 Jun;42(6):541-6. doi: 10.1016/j.nucmedbio.2015.02.002. Epub 2015 Feb 11. Nucl Med Biol. 2015. PMID: 25735223
-
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors.Mol Pharm. 2024 Apr 1;21(4):1919-1932. doi: 10.1021/acs.molpharmaceut.3c01173. Mol Pharm. 2024. PMID: 38557163
-
SPECT/CT Imaging of the Novel HER2-Targeted Peptide Probe 99mTc-HYNIC-H6F in Breast Cancer Mouse Models.J Nucl Med. 2017 May;58(5):821-826. doi: 10.2967/jnumed.116.183863. Epub 2017 Jan 19. J Nucl Med. 2017. PMID: 28104744
-
New small 99mTc-labeled peptides for HER2 receptor imaging.Eur J Med Chem. 2017 Feb 15;127:1012-1024. doi: 10.1016/j.ejmech.2016.11.011. Epub 2016 Nov 9. Eur J Med Chem. 2017. PMID: 27842890
-
Direct In Vivo Comparison of 99mTc-Labeled Scaffold Proteins, DARPin G3 and ADAPT6, for Visualization of HER2 Expression and Monitoring of Early Response for Trastuzumab Therapy.Int J Mol Sci. 2022 Dec 2;23(23):15181. doi: 10.3390/ijms232315181. Int J Mol Sci. 2022. PMID: 36499504 Free PMC article.
Cited by
-
Nanoparticles labeled with gamma-emitting radioisotopes: an attractive approach for in vivo tracking using SPECT imaging.Drug Deliv Transl Res. 2023 Jun;13(6):1546-1583. doi: 10.1007/s13346-023-01291-1. Epub 2023 Feb 22. Drug Deliv Transl Res. 2023. PMID: 36811810 Review.
-
Tracking tools of extracellular vesicles for biomedical research.Front Bioeng Biotechnol. 2022 Nov 18;10:943712. doi: 10.3389/fbioe.2022.943712. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36466335 Free PMC article. Review.
-
In vivo SPECT imaging of Tc-99m radiolabeled exosomes from human umbilical-cord derived mesenchymal stem cells in small animals.Biomed J. 2024 Oct;47(5):100721. doi: 10.1016/j.bj.2024.100721. Epub 2024 Apr 16. Biomed J. 2024. PMID: 38636899 Free PMC article.
-
Live long and active: Polypeptide-mediated assembly of antibody variable fragments.Adv Drug Deliv Rev. 2020 Dec;167:1-18. doi: 10.1016/j.addr.2020.10.017. Epub 2020 Oct 28. Adv Drug Deliv Rev. 2020. PMID: 33129938 Free PMC article.
-
Current Perspectives on Clinical Use of Exosomes as a Personalized Contrast Media and Theranostics.Cancers (Basel). 2020 Nov 16;12(11):3386. doi: 10.3390/cancers12113386. Cancers (Basel). 2020. PMID: 33207614 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous